September 18, 2024
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to report that on 18 September 2024, it had completed the issue of shares in part settlement of deferred executive salaries and director fees (the “Compensation Shares” or the “Shares for Debt”) as previously announced in a news release dated 17 July 2024.
The Shares for Debt arrangement comprised the issue of 22,348,980 Chess Depository Instruments (“CDIs”) at a deemed issue price of A$0.02 per CDI, equivalent to A$446,979.60 as detailed in Table 1 below. Each new CDI issued under the Placement will rank equally with existing CDIs on issue and each CDI will represent a beneficial interest in one common share of the Company. The issuance of the Shares for Debt was subject to TSXV and shareholder approval which was obtained at the annual general meeting held on 11 September 2024 (the “Meeting”).

The Compensation Shares and Shares for Debt were issued upon receipt of shareholder approval, as required by the Australian Securities Exchange Listing Rules, at the Meeting. An Appendix 2A was announced to the ASX on 18 September 2024 and provides further detail on the issue of the Compensation Shares and Shares for Debt.
The Share for Debt arrangement will reduce the Company’s liabilities.
The CDIs issued under the Placement are subject to a TSX Venture Exchange (“TSXV”) “hold period” of 4 months and one day from the date of issue of the CDIs.
The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from registration is available. This announcement does not constitute an offer to sell or a solicitation of an offer to buy any of the Securities within the United States or to, or for the account or benefit of, U.S. Persons (as defined under Regulation S under the U.S. Securities Act), nor shall there be any sale of these Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Click here for the full ASX Release
This article includes content from Sarama Resources, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
SRR:AU
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
The Conversation (0)
29 May
Completion of Tranche 1 Equity Placement & Cleansing Notice
Sarama Resources (SRR:AU) has announced Completion of Tranche 1 Equity Placement & Cleansing NoticeDownload the PDF here. Keep Reading...
20 May
Sarama Raises A$1.5m in Private Placement
Sarama Resources (SRR:AU) has announced Sarama Raises A$1.5m in Private PlacementDownload the PDF here. Keep Reading...
18 May
Trading Halt
Sarama Resources (SRR:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
15 May
Q1 2026 Interim Financial Statements
Sarama Resources (SRR:AU) has announced Q1 2026 Interim Financial StatementsDownload the PDF here. Keep Reading...
15 May
Qtly Activities Report - Q1 26 Mgmt's Discussion & Analysis
Sarama Resources (SRR:AU) has announced Qtly Activities Report - Q1 26 Mgmt's Discussion & AnalysisDownload the PDF here. Keep Reading...
9h
Top 5 Australian Mining Stocks This Week: CGN Resources Spikes on Maiden Gold Drilling
Welcome to the Investing News Network's weekly round-up of the top-performing mining stocks on the ASX.Companies focused on gold, helium and critical minerals shone this week, with copper and gold explorer CGN Resources taking the top spot.Read on to discover this week's top gaining Australian... Keep Reading...
9h
Tavi Costa: Gold, Silver, Copper — Outlook, Plus My Strategy Now
Tavi Costa, CEO of Azuria Capital, shares his outlook for gold, silver and copper. He also speaks about the commodities space more broadly, emphasizing the importance of holding hard assets as the US treasury market struggles to retain credibility.Don't forget to follow us @INN_Resource for... Keep Reading...
9h
Rick Rule: Oil Bull Case, Plus the Only 3 Gold Stocks You Need
Rick Rule, proprietor at Rule Investment Media, shares his short- and long-term oil outlook. He also weighs in on gold's price pullback, referring to it as a "hiatus" similar to the one seen in 1975. Click here for this year's Rule Symposium recordings. Don't forget to follow us @INN_Resource... Keep Reading...
13h
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for July 22nd & 23rd
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Precious Metals & Critical Minerals Virtual Investor Conference to be held July 22nd & 23rd, 2026.Individual investors, institutional investors, advisors, and analysts are invited to... Keep Reading...
15 July
Rich Checkan: Gold Cheap, Silver Cheaper — Now is The Time to Buy
Rich Checkan, president and COO of Asset Strategies International, shares his outlook for gold and silver, saying the metals are currently at sale prices. Both could still go lower, but he encouraged investors to act sooner than later."Take a little of your cash, deploy it now — lock in that... Keep Reading...
15 July
Brien Lundin: Gold's "Unique" Bull Market — Major vs. Junior Stocks
Brien Lundin, editor of Gold Newsletter, shares his thoughts on the pullback in gold and silver prices, saying that finding a bottom will take time. If seasonality is in effect this year, he sees that process happening in mid-July to mid-August. "That's really our last chance — our best chance —... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00






